エディットフォース株式会社

  • STRENGTH
  • PLATFORM
  • PIPELINE
  • COMPANY
  • NEWS
  • CONTACT
  • JP/ EN
  1. HOME
  2. NEWS

News

All

category

news

release

media

information

2023.03.22
release

FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES

2022.11.11
information

EditForce achieved establishment of a high-throughput construction method for PPR protein gene and its application for splicing control in human cells

2022.09.30
information

EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells

2022.06.27
release

EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT

2021.08.20
information

Announcement of Capital Reduction

2021.06.30
release

EditForce completed fund raising by third-party allotment and AMED adopts our program

2021.05.19
information

EditForce completed fund raising by third-party allotment

2019.12.26
information

EDITFORCE AND SOLASIA ENTER INTO JOINT R&D AGREEMENT

2019.03.01
information

EditForce raises 870 million JPY

1 2

archive

All

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2019

contact

Feel free to contact us when you have any questions or concerns.

Contact
  • HOME
  • STRENGTH
  • PLATFORM
    • Publication
  • PIPELINE
  • COMPANY
    • Top message
    • Philosophy
    • About
    • History
    • Team
    • Access
  • NEWS
  • CONTACT
  • PRIVACY POLICY
© EditForce, Inc. 2025
MENU
  • ホームページ
PAGE TOP
当サイトではお客様の利便性向上のためにcookieを使用しています。OK詳しくはこちら